Kornitzer Capital Management’s PAVmed PAVM Stock Holding History

Kornitzer Capital Management’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-367	Closed	-$1.41M	–	529
2021 Q3	$1.41M	Buy	+367	New	+$1.16M	0.02%	411

Other funds holding PAVM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Kornitzer Capital Management's PAVM Position: Q4 2021 in Review

Kornitzer Capital Management sold out of PAVmed (PAVM) in Q4 2021, closing a stake of 367 shares — an estimated $1.41M sold.

Kornitzer Capital Management first reported a position in PAVM in Q3 2021 and held it in 1 quarter. The position peaked at $1.41M in Q3 2021. 105 funds tracked by Wall St. Rank hold PAVM as of Q4 2021.

Kornitzer Capital Management reported no remaining PAVmed position as of Q4 2021 after selling out during the quarter.
Kornitzer Capital Management sold 367 PAVmed shares in Q4 2021, an estimated $1.41M.
Kornitzer Capital Management first reported a position in PAVmed in Q3 2021 and held it in 1 quarter.
Kornitzer Capital Management's PAVmed position peaked at $1.41M in Q3 2021.
105 funds tracked by Wall St. Rank held PAVmed as of Q4 2021.

Based on Kornitzer Capital Management's 13F filing for Q4 2021, filed 1 Feb 2022.